Filing Details
- Accession Number:
- 0001127602-21-019904
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2021-06-15 16:11:51
- Reporting Period:
- 2021-06-11
- Accepted Time:
- 2021-06-15 16:11:51
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
885590 | Bausch Health Companies Inc. | BHC | Pharmaceutical Preparations (2834) | 000000000 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1558676 | Sam Eldessouky | 400 Somerset Corporate Boulevard Bridgewater NJ 08807 | Evp & Chief Financial Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Shares, No Par Value | Disposition | 2021-06-11 | 17,000 | $31.68 | 116,857 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | S | Direct |
Footnotes
- The price in Column 4 reflects the average weighted sale price for the transactions aggregated on this Form 4. The sales price per share reported on this Form 4 range from $31.67 to $31.711. The reporting person will provide to the Commission, the issuer and any stockholder, upon request, full information regarding the number of shares sold at each separate price.